Skip to main content
Log in

Taking BETs on cardiomyocyte differentiation

  • Research Briefing
  • Published:

From Nature Cardiovascular Research

View current issue Submit your manuscript

Motivated by a CRISPR screen, in vitro and in vivo studies identified an essential role for the bromodomain and extraterminal domain (BET) family member BRD4 in the differentiation of second heart field progenitors into cardiomyocytes. Single-cell transcriptomic studies showed that BRD4 deficiency affects a specific subset of cardiac progenitor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: The role of BRD4 in cardiomyocyte differentiation.

References

  1. Padmanabhan, A. et al. BRD4 (bromodomain-containing protein 4) interacts with GATA4 (GATA binding protein 4) to govern mitochondrial homeostasis in adult cardiomyocytes. Circulation 142, 2338–2355 (2020). This paper shows how BRD4 interacts with tissue-specific transcription factors to mediate cardiomyocyte homeostasis.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Linares-Saldana, R. et al. BRD4 orchestrates genome folding to promote neural crest differentiation. Nat. Genet. 53, 1480–1492 (2021). This paper elucidates the role of BRD4 in mediating genome folding and its consequences for neural crest differentiation.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Padmanabhan, A. & Haldar, S. M. Drugging transcription in heart failure. J. Physiol. 598, 3005–3014 (2020). A review article that discusses the therapeutic potential of BET inhibitors.

    Article  CAS  PubMed  Google Scholar 

  4. Kwon, C. et al. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc. Natl Acad. Sci. USA 104, 10894–10899 (2007). This paper reports that WNT signaling is necessary for maintaining cardiac progenitor cells.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  5. Morton, S. U., Quiat, D., Seidman, J. G. & Seidman, C. E. Genomic frontiers in congenital heart disease. Nat. Rev. Cardiol. 19, 26–42 (2022). A review article that highlights advances in genomic understanding of congenital heart disease.

    Article  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Padmanabhan, A. et al. A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00431-1 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taking BETs on cardiomyocyte differentiation. Nat Cardiovasc Res 3, 265–266 (2024). https://doi.org/10.1038/s44161-024-00443-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-024-00443-x

  • Springer Nature Limited

Navigation